ELVN fund manager activity
Enliven Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q2 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | New | 7,500 | $380,625 | 0.00% | Aug 14, 2026 |
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller - Duquesne Family Office | Sold out | — | — | 0.00% | Feb 17, 2026 |